Chad Oh

Chad Oh discloses dealings in AEON Biopharma, Inc. to SEC (Form 4). Over a trading history stretching from 31 August 2024 to 4 March 2026, the count stands at 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 11 March 2026 with a share grant in AEON Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 7 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.